Unknown PHASE2/PHASE3 INTERVENTIONAL NCT00391144

Avastin for CNV Secondary to Pattern Dystrophy

Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy

Sponsor: University of Trieste

Conditions Choroidal Neovascularization Secondary to Pattern Dystrophy

Interventions intravitreal triamcinolone injection of avastin (1.25 mg)

Updated 4 times since 2017 Last updated: Oct 20, 2006 Started: Jul 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Choroidal Neovascularization Secondary to Pattern Dystrophy, this trial is ongoing. The trial is conducted by University of Trieste and has accumulated 4 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Trieste

Data source: University of Trieste

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trieste, Italy